MENU

Bright Minds Biosciences Inc (CSE:DRUG)

73.54 UNCHANGED
Delayed Quote Updated: 3:01 PM EDT, Oct 7, 2026 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 0
Open 73.54
Bid (Size) 64.87 (100)
Ask (Size) 80.51 (100)
Prev. Close 73.54
Today's Range 73.54 - 73.54
52wk Range 68.02 - 170.00
Shares Outstanding N/A
Dividend Yield N/A

Performance

52-Week Range 56.7% below 52-week high
73.54
68.0252W Low 170.0052W High
1 Week 1.3% below 1-week high
68.021W Low 74.501W High

Bright Minds Biosciences Inc (DRUG) traded between $68.02 and $170.00 over the past 52 weeks and last traded at $73.54, 56.7% below its 52-week high. Over the past week it ranged between $68.02 and $74.50.

Past 12 Months
+3.7%
-19.8%
-23.4%
-35.5%
-36.5%
+4.9%
1W +$2.60
1M -$18.17
3M -$22.43
6M -$40.45
YTD -$42.26
1Y +$3.43

DRUG was +4.9% over the past year, -35.5% over six months, -36.5% year to date, +3.7% in the last week.

12 Months vs Market
DRUG
+4.9%
DIA
+9.7%
SPY
+16.2%
QQQ
+25.3%
IWM
+13.7%

Over the past 12 months DRUG returned +4.9% versus DIA (Dow) +9.7%, SPY (S&P 500) +16.2%, QQQ (Nasdaq 100) +25.3% and IWM (Russell 2000) +13.7%.

Volume & Liquidity
1W
710.0
1M
1.0K
3M
810.0
6M
822.0
YTD
931.0
1Y
949.0

DRUG's 3-month average daily volume is 810.0.

More News

Read More

Frequently Asked Questions

Is Bright Minds Biosciences Inc publicly traded?
Yes, Bright Minds Biosciences Inc is publicly traded.
What exchange does Bright Minds Biosciences Inc trade on?
Bright Minds Biosciences Inc trades on the Canadian Securities Exchange
What is the ticker symbol for Bright Minds Biosciences Inc?
The ticker symbol for Bright Minds Biosciences Inc is DRUG on the Canadian Securities Exchange
What is the current price of Bright Minds Biosciences Inc?
The current price of Bright Minds Biosciences Inc is 73.54
When was Bright Minds Biosciences Inc last traded?
The last trade of Bright Minds Biosciences Inc was at 10/07/26 03:01 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
TOP
Email a Story